Maynard Um
-
-
-
-
-
-
-
Buy the pullback in this major pharma stock: Bernstein
-
-
-
-
-
-
-
AstraZeneca receives FDA approval for Truqap prostate cancer treatment
-
-
-
-
-
-
-
FDA extends review period for AstraZeneca breast cancer drug camizestrant
-
-
-
-
-
-
-
AstraZeneca drug combo shows survival benefit in bladder cancer trial
-
-
-
-
-
-
-
AstraZeneca, Amgen partner with FDA to test real-time AI trial monitoring
-
-
-
-
-
-
-
FDA approves multiple generics of Farxiga
-
-
-
-
-
-
-
AstraZeneca drug meets goals in two COPD trials
-
417,357 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

